Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil C Josephson

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Blood Advances|January 4, 2018
Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiativeJill M Johnsen, Shelley N Fletcher, Haley Huston, et al.
Blood|January 7, 2012
Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patientsJerry S Powell, Neil C Josephson, Doris Quon, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2022
Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United StatesJill M Johnsen, Shelley N Fletcher, Angela Dove, et al.
Plos One|May 14, 2013
Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonanceKenneth B Lewis, Richard J Hughes, Melinda S Epstein, et al.
Blood|October 17, 2020
BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expressionBarbara A Konkle, Christopher E Walsh, Miguel A Escobar, et al.
British Journal of Haematology|September 12, 2014
Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG studyJerry S Powell, Shashikant Apte, Hervé Chambost, et al.
Blood|November 24, 2011
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patientsAmy D Shapiro, Margaret V Ragni, Leonard A Valentino, et al.
Blood|November 15, 2013
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia AJohnny Mahlangu, Jerry S Powell, Margaret V Ragni, et al.
The New England Journal of Medicine|December 12, 2017
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's LymphomaJoseph M Connors, Wojciech Jurczak, David J Straus, et al.
The New England Journal of Medicine|December 6, 2013
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia BJerry S Powell, K John Pasi, Margaret V Ragni, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Blood Advances|January 4, 2018
Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiativeJill M Johnsen, Shelley N Fletcher, Haley Huston, et al.
Blood|January 7, 2012
Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patientsJerry S Powell, Neil C Josephson, Doris Quon, et al.
Journal of Thrombosis and Haemostasis : JTH|June 30, 2022
Results of genetic analysis of 11 341 participants enrolled in the My Life, Our Future hemophilia genotyping initiative in the United StatesJill M Johnsen, Shelley N Fletcher, Angela Dove, et al.
Plos One|May 14, 2013
Phenotypes of allo- and autoimmune antibody responses to FVIII characterized by surface plasmon resonanceKenneth B Lewis, Richard J Hughes, Melinda S Epstein, et al.
Blood|October 17, 2020
BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expressionBarbara A Konkle, Christopher E Walsh, Miguel A Escobar, et al.
British Journal of Haematology|September 12, 2014
Long-acting recombinant factor IX Fc fusion protein (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG studyJerry S Powell, Shashikant Apte, Hervé Chambost, et al.
Blood|November 24, 2011
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patientsAmy D Shapiro, Margaret V Ragni, Leonard A Valentino, et al.
Blood|November 15, 2013
Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia AJohnny Mahlangu, Jerry S Powell, Margaret V Ragni, et al.
The New England Journal of Medicine|December 12, 2017
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's LymphomaJoseph M Connors, Wojciech Jurczak, David J Straus, et al.
The New England Journal of Medicine|December 6, 2013
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia BJerry S Powell, K John Pasi, Margaret V Ragni, et al.
Pageof 2